Vaccine health study

Event description

  • Free
  • Health and wellness
  • Open to the public
  • Science


The CDC is partnering with ASU on a longitudinal study to investigate immune response of influenza and COVID-19 vaccines.

Vaccination: Participants will be randomly assigned an FDA approved influenza and COVID-19 vaccine that will be administered simultaneously or 28 days apart.

Blood draw: There will be a blood collection for every in- person visit to measure antibody waning.

Weekly follow-up survey: For surveillance purposes, participants will complete a brief survey to determine the presence of new flu-like symptoms.

Those who qualify: Healthy adults 18–64 that have not received the current season's influenza or COVID-19 vaccination in the past six months. 


  • Voluntary participation throughout the flu season
  • Up to 6 visits
  • Up to $200 compensation 

Schedule an appointment here. For questions, contact

View the flyer here.

Additional information

Event contact

Monday, November 20, 2023

Available every weekday until the end of November.

12:00 am11:59 pm (MST)


Biodesign Institute, Room A250